NCT05829798 is a NA clinical trial of SYNOLIS VA 80/160 in Osteoarthritis, Knee, sponsored by Aptissen SA.

Who is sponsoring NCT05829798?

NCT05829798 is sponsored by Aptissen SA.

What drugs are being tested in NCT05829798?

Interventions in NCT05829798: SYNOLIS VA 80/160, SYNOLIS VA 40/80.

What condition does NCT05829798 study?

NCT05829798 studies Osteoarthritis, Knee.

Is NCT05829798 still recruiting?

NCT05829798 is currently completed. Last updated 26 April 2023.

Last reviewed 2023-04-26 · How we verify

NCT05829798

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

Completed NA Last updated 26 April 2023

What this trial tests

NA trial testing SYNOLIS VA 80/160 in Osteoarthritis, Knee in 82 participants. Completed in 1 October 2021.

Timeline

14 January 2021

Primary endpoint
1 October 2021

1 October 2021

Quick facts

Lead sponsor	Aptissen SA
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	82
Start date	14 January 2021
Primary completion	1 October 2021
Estimated completion	1 October 2021
Sites	3 locations across Poland

Drugs / interventions tested

SYNOLIS VA 80/160
SYNOLIS VA 40/80

Conditions studied

Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →

Sponsor

Aptissen SA

Who can join

Adults 35 to 75, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicentre, independent assessment study on SYNOLIS VA 80/160 and SYNOLIS VA 40/80 over a period of 24 weeks

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting

Other Aptissen SA trials

Trials by the same sponsor.

NCT05337540 — A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the K · NA · completed
NCT05422976 — EVI-01-IT Safety Study · NA · completed
NCT05829850 — An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Sympto · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05829798 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aptissen SA
Last refreshed: 26 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05829798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing